|
Cytochrome P450 Family 19
|
D12.776.422.220.453.489 |
|
|
Cytochrome P-450 Enzyme System
|
D12.776.422.220.453 |
|
|
Hemorrhagic Fevers, Viral
|
C01.925.782.417 |
|
|
Prussian Blue Reaction
|
E05.200.750.600.670.660 |
|
|
Mitochondrial Turnover
|
G04.599 |
|
|
Diet Surveys
|
N06.850.505.616.300 |
|
|
Nutrition Surveys
|
N06.850.505.616 |
|
|
Fetal Therapies
|
D046128 |
[Prenatal interventions to correct fetal anomalies or treat FETAL DISEASES in utero. Fetal therapies include several major areas, such as open surgery; FETOSCOPY; pharmacological therapy; INTRAUTERINE TRANSFUSION; STEM CELL TRANSPLANTATION; and GENETIC THERAPY.
] |
|
Ebola Vaccines
|
D046129 |
[Vaccines or candidate vaccines used to prevent EBOLA HEMORRHAGIC FEVER.
] |
|
Linear Models
|
E05.599.835.750 |
|
|
Receptors, Thromboxane
|
D12.776.543.750.695.200.800 |
|
|
Receptors, Eicosanoid
|
D12.776.543.750.695.200 |
|
|
Cryoultramicrotomy
|
E01.370.225.750.600.530.160 |
|
|
Microtomy
|
E01.370.225.750.600.530 |
|
|
Arthroplasty, Replacement, Shoulder
|
E04.650.110.299 |
|
|
Arthroplasty, Replacement
|
E04.650.110 |
|
|
Cytochrome P450 Family 2
|
D12.776.422.220.453.491 |
|
|
Anticodon
|
G05.360.335.060 |
|
|
Erythema Nodosum
|
C17.800.174.600.375 |
|
|
Osteotomy, Sagittal Split Ramus
|
E06.645.637 |
|
